Efficacy and tolerability of brivaracetam as adjunctive therapy in children with drug-resistant epilepsy: a single-center prospective cohort study

Fen Zhao, Wenchao Zhang, Qi Zhang, Wei Jiang, Guanglei Wang, Deyue Li, Hongwei Zhang

Open source

DOI
10.1016/j.jfma.2026.11.008
Published
2026-11
Container
Journal of the Formosan Medical Association
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jfma.2026.11.008,
  title = {Efficacy and tolerability of brivaracetam as adjunctive therapy in children with drug-resistant epilepsy: a single-center prospective cohort study},
  author = {Fen Zhao and Wenchao Zhang and Qi Zhang and Wei Jiang and Guanglei Wang and Deyue Li and Hongwei Zhang},
  year = {2026},
  journal = {Journal of the Formosan Medical Association},
  doi = {10.1016/j.jfma.2026.11.008},
  url = {https://doi.org/10.1016/j.jfma.2026.11.008}
}

RIS

TY  - JOUR
TI  - Efficacy and tolerability of brivaracetam as adjunctive therapy in children with drug-resistant epilepsy: a single-center prospective cohort study
AU  - Fen Zhao
AU  - Wenchao Zhang
AU  - Qi Zhang
AU  - Wei Jiang
AU  - Guanglei Wang
AU  - Deyue Li
AU  - Hongwei Zhang
PY  - 2026
JO  - Journal of the Formosan Medical Association
DO  - 10.1016/j.jfma.2026.11.008
UR  - https://doi.org/10.1016/j.jfma.2026.11.008
ER  - 

APA

Zhao, F., Zhang, W., Zhang, Q., Jiang, W., Wang, G., Li, D., & Zhang, H. (2026). Efficacy and tolerability of brivaracetam as adjunctive therapy in children with drug-resistant epilepsy: a single-center prospective cohort study. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2026.11.008

Source records